FibroBiologics, Inc. filed 2 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-08-24. Between them they name 2 people. Each change below is quoted from the filing and linked to it.
Every change, newest first
Appointed: Leigh Steinberg, Director, effective 2026-08-20
On August 20, 2026, the Board of Directors (the "Board") of FibroBiologics, Inc. (the "Company") appointed Leigh Steinberg as a Class II director of the Board, effective August 20, 2026, to serve until the expiration of his term at the 2028 annual meeting of stockholders.
Appointed: Kathleen Rubins, Director, effective 2026-07-08
On July 8, 2026, the Board appointed Kathleen Rubins, Ph.D. as a Class III director of the Board, effective July 8, 2026, to serve until the expiration of her term at the 2029 annual meeting of stockholders.
FibroBiologics, Inc.'s funding history
Find people with the same kind of experience as the Director at FibroBiologics, Inc., with the record behind each one.
Find candidates like Director at FibroBiologics, Inc.New leaders review vendors and budgets in their first months. Get an alert the next time FibroBiologics, Inc. is in the news or changes leadership.
Get an alert when FibroBiologics, Inc. changes leadershipTools for this story
Each opens in a new tab, filled in for FibroBiologics, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.